Our expert scientists. Your drug discovery pipeline.
Understanding the remyelination efficiency of your drug candidate in three dimensions with a realistic cell structure can help you on the best route to clinic.
At Aquila, we offer a central nervous system (CNS) slice model as a transitional link between in vitro cell culture and in vivo investigations, and as a step up in complexity from our OPC screening assay.
Please get in touch to learn how our CNS slice remyelination model can help with your project.